Private Advisor Group LLC bought a new position in Agilent Technologies, Inc. (NYSE:A) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 8,030 shares of the medical research company’s stock, valued at approximately $532,000.

A number of other hedge funds also recently added to or reduced their stakes in the business. Advisor Group Inc. grew its stake in Agilent Technologies by 0.3% in the 2nd quarter. Advisor Group Inc. now owns 3,959 shares of the medical research company’s stock valued at $235,000 after buying an additional 10 shares during the last quarter. Bronfman E.L. Rothschild L.P. grew its stake in Agilent Technologies by 0.8% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 4,658 shares of the medical research company’s stock valued at $276,000 after buying an additional 35 shares during the last quarter. Veritable L.P. grew its stake in Agilent Technologies by 0.4% in the 2nd quarter. Veritable L.P. now owns 10,896 shares of the medical research company’s stock valued at $646,000 after buying an additional 40 shares during the last quarter. Balentine LLC grew its stake in Agilent Technologies by 2.9% in the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock valued at $106,000 after buying an additional 50 shares during the last quarter. Finally, Kingfisher Capital LLC grew its stake in Agilent Technologies by 0.3% in the 2nd quarter. Kingfisher Capital LLC now owns 22,643 shares of the medical research company’s stock valued at $1,343,000 after buying an additional 58 shares during the last quarter.

Shares of Agilent Technologies, Inc. (NYSE A) opened at $67.00 on Tuesday. Agilent Technologies, Inc. has a 1 year low of $45.36 and a 1 year high of $70.93. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30. The company has a market cap of $21,684.77, a P/E ratio of 28.43, a PEG ratio of 2.04 and a beta of 1.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, topping the consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.96%. The company had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same quarter in the previous year, the company earned $0.59 EPS. Agilent Technologies’s revenue was up 7.0% on a year-over-year basis. research analysts expect that Agilent Technologies, Inc. will post 2.58 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be issued a $0.149 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.89%. The ex-dividend date of this dividend is Friday, December 29th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio is 25.24%.

In other news, CFO Didier Hirsch sold 1,200 shares of the business’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $66.00, for a total value of $79,200.00. Following the sale, the chief financial officer now owns 164,202 shares of the company’s stock, valued at $10,837,332. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Mark Doak sold 4,154 shares of the business’s stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $67.00, for a total transaction of $278,318.00. Following the completion of the sale, the vice president now directly owns 68,270 shares in the company, valued at approximately $4,574,090. The disclosure for this sale can be found here. Insiders sold 150,268 shares of company stock valued at $10,311,406 in the last quarter.

Several research firms have issued reports on A. Morgan Stanley restated an “overweight” rating on shares of Agilent Technologies in a research report on Tuesday, November 14th. Deutsche Bank set a $68.00 price target on shares of Agilent Technologies and gave the stock a “buy” rating in a research report on Wednesday, August 16th. Bank of America raised their price target on shares of Agilent Technologies from $66.00 to $68.00 and gave the stock an “equal weight” rating in a research report on Wednesday, August 16th. J P Morgan Chase & Co restated an “overweight” rating and issued a $70.00 price target on shares of Agilent Technologies in a research report on Wednesday, August 16th. Finally, Janney Montgomery Scott raised their price target on shares of Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a research report on Wednesday, August 16th. Six investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $68.34.

ILLEGAL ACTIVITY WARNING: “Private Advisor Group LLC Buys Shares of 8,030 Agilent Technologies, Inc. (A)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/12/12/private-advisor-group-llc-buys-shares-of-8030-agilent-technologies-inc-a.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Stock Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related stocks with our FREE daily email newsletter.